Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet’s Disease

Intestinal Behçet’s disease is a rare, immune-mediated chronic intestinal inflammatory disease; therefore, clinical trials to optimize the management and treatment of patients are scarce. Moreover, intestinal Behçet’s disease is difficult to treat and often requires surgery because of the failure of...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jihye, Cheon, Jae Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254627/
https://www.ncbi.nlm.nih.gov/pubmed/29788675
http://dx.doi.org/10.5009/gnl17462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254627/
https://www.ncbi.nlm.nih.gov/pubmed/29788675
http://dx.doi.org/10.5009/gnl17462

Ejemplares similares